Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05662046
Other study ID # Mediopied-PC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 14, 2018
Est. completion date June 14, 2018

Study information

Verified date December 2022
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Midfoot and backfoot deformities are well described in children with Cerebral palsy. However, data regarding forefoot deformities in Cerebral palsy remain scarce in a population were foot deformities are the most frequent musculo-skeletal deformities.


Description:

Foot deformities are the most frequent musculo-skeletal deformities in children with Cerebral palsy. Pain starts in the foot, especially during gait in Cerebral Palsy Children (GMFCS I and II) and induce gait limitations, balance disorders, wounds, aesthetic disorders and difficulties to support shoes. Metatarsus Adductus is the most common foot deformity in children with or without disorder, occuring on 1-2/1000 births. In 4 to 14% of the children, evolution is not favorable at 5 years. In that case, the diagnostic of Cerebral palsy have to be considered.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date June 14, 2018
Est. primary completion date June 14, 2018
Accepts healthy volunteers No
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: - Child who benefit a standardised clinical evaluation before a 3D Gait Analysis with forefoot deformity measure - Child age less than 18 years old - Child with left or right unilateral cerebral palsy - Walking child ( GMFCS score I, II or III) - In case of several 3D Gait Analysis for the child: the 3D gait analysis was chosen first before any local spasticity treatment with botulinic toxin injection or the 3D gait evaluation the more far from local spastica treatment with botulinic toxin injection was chosen in second . Exclusion Criteria: - Hemiplegia due to another etiology - History of lower limb or foot surgery before the clinical evaluation - Local spasticy treatment with botulinic toxin injection less than 3 months before the clinical evaluation - Participation refusal

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Houx Brest
France PRIGENT Concarneau

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of the forefoot deformity prevalence in plegia and non-plegia foot during gait in unilateral cerebral palsy children we report in our population the forefoot axis measured by the angle between the heel bisector and the axis between the second and third metatarsal. 1 day
Secondary Anthropometric factors (age) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report the age (years mean, standard deviation) of the patients CP 1 day
Secondary Anthropometric factors (sexe) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report the sexe of the patients (female or male) 1 day
Secondary Anthropometric factors (type of cerebral palsy)associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report the plegia side of the patients cerebral palsy : right or left 1 day
Secondary functional factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report the GMFCS score of the patients cerebral palsy : GMFCS 1, 2, 3, 4 or 5 (4-5 non ambulant 1-3 ambulant children) 1 day
Secondary biomechanical osteoarticular factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report biomechanical osteoarticular factors : hindfoot axis, foot dorsiflexion, footprint, tibial torsion, femoral antetorsion, leg length inequality) , Spasticity of lower limb muscle (Modified Ashworth Scale and Tardieu Scale) and Motricity of lower limb muscle ( Boyd scale and MRC evaluation) 1 day
Secondary Spasticity factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report the Spasticity of lower limb muscle (Modified Ashworth Scale and Tardieu Scale) 1 day
Secondary Motricity factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy. we report the motricity of lower limb muscle ( Boyd scale and MRC evaluation) 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2